Home > Insider Trading > Filing (0001209191-20-052334)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1699382	Pmv Pharmaceuticals Inc.	PMVP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1207833	L Arnold Oronsky	C/O Pmv Pharmaceuticals, Inc. 8 Clarke Drive, Suite 3 Cranbury NJ 08512		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-25	55,000	$18.00	55,000	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-09-29	1,620,101	$0.00	1,675,101	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-09-29	3,488,398	$0.00	5,163,499	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-09-29	1,040,654	$0.00	6,204,153	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-09-29	265,203	$0.00	6,469,356	No	4	C	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series Seed Preferred Stock	Disposition	2020-09-29	1,620,101	$0.00	1,620,101	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-09-29	3,488,398	$0.00	3,488,398	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-09-29	1,040,654	$0.00	1,040,654	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-09-29	265,203	$0.00	265,203	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The shares are directly held by InterWest Partners X, LP ("InterWest X"). InterWest Management Partners X, LLC ("IMP X"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date.